NEW YORK (AP) _ Synergy Pharmaceuticals Inc. (SGYP) on Wednesday reported a loss of $59.9 million in its fourth quarter.
The New York-based company said it had a loss of 31 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
For the year, the company reported that its loss widened to $198.6 million, or $1.21 per share.
Synergy Pharma shares have dropped almost 7 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.68, a rise of 76 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGYP at https://www.zacks.com/ap/SGYP
Keywords: Synergy Pharmaceuticals, Earnings Report